Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Myovant Sciences GmbH
Scientific Title
A Multinational Phase 3 Randomized, Open-label, Parallel Group Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer